Tetrandrine Alleviates Pulmonary Fibrosis by Modulating Lung Microbiota‐Derived Metabolism and Ameliorating Alveolar Epithelial Cell Senescence
Phytotherapy Research · 2025
DOI: 10.1002/ptr.8374 ↗At a glance
Journal article in Phytotherapy Research, 2025. Written by Jinzhong Zhuo and 10 co-authors. Institution: Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China. Major MEDLINE topics: Benzylisoquinolines, Pulmonary Fibrosis, Cellular Senescence, Alveolar Epithelial Cells. Cited 9 times so far (Crossref); 48 references. Funded by: Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China.
Abstract (original language)
Tetrandrine (TET) is a minimally toxic drug extracted from the root of Stephania tetrandra. We previously demonstrated that TET could ameliorate pulmonary fibrosis (PF) by modulating autophagy. However, the mechanism behind TET's protective effects on PF remains unclear. In this study, we utilized 16S rRNA gene sequencing, nontargeted metabolomic analysis, and network pharmacology to identify changes in lung microbiota and metabolites that mediate alveolar epithelial cell senescence in bleomycin (BLM)‐induced PF in mice. Additionally, we employed Western blot analysis, RT‐PCR, and immunofluorescence staining to investigate the in vitro and in vivo effects of TET and its influential bacterial metabolites on PF. The TET intervention alleviated PF by regulating the compositions of lung microbial communities ( Streptococcus , Micrococcus , Acinetobacter , Altererythrobacter , Atopostipes , Candidatus Cloacimonas , Clostridium sensu stricto 1 , Sphingomonas , Listeria , Blautia , and Pseudomonas ) and metabolites (3,4‐dihydroxyphenylpropionic acid (3,4‐DHPPA), 6‐Aminonicotinamide, N‐acetyl‐5‐methoxykynuramine, and resiniferatoxin). Through network pharmacological analysis, it was determined that 3,4‐DHPPA played a crucial role in alleviating PF by further inhibiting the senescence of alveolar epithelial cells, a finding further validated in ex vivo experiments. TET mitigated BLM‐induced PF in murine models through the modulation of lung microbiota composition and metabolism. Specifically, TET augmented the level of the microbiota‐derived metabolite, 3,4‐DHPPA, which in turn attenuated alveolar epithelial cell senescence.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- School of Public Health, Southern Medical University, Guangzhou, China.
ORCID profiles: Hangming Dong
Funding
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Natural Science Foundation of China
Cite
APA
Zhuo, J., Chu, L., Liu, D., Zhang, J., Chen, W., Huang, H., Yu, Q., Meng, X., Zou, F., Cai, S., & Dong, H. (2025). Tetrandrine Alleviates Pulmonary Fibrosis by Modulating Lung Microbiota‐Derived Metabolism and Ameliorating Alveolar Epithelial Cell Senescence. Phytotherapy Research. https://doi.org/10.1002/ptr.8374
Vancouver
Zhuo J, Chu L, Liu D, Zhang J, Chen W, Huang H, et al. Tetrandrine Alleviates Pulmonary Fibrosis by Modulating Lung Microbiota‐Derived Metabolism and Ameliorating Alveolar Epithelial Cell Senescence. Phytotherapy Research. 2025. doi:10.1002/ptr.8374
BibTeX
@article{Zhuo2025,
author = {Zhuo, Jinzhong and Chu, Lanhe and Liu, Dongyu and Zhang, Jinming and Chen, Weimou and Huang, Haohua and Yu, Qi and Meng, Xiaojin and Zou, Fei and Cai, Shaixi and Dong, Hangming},
title = {Tetrandrine Alleviates Pulmonary Fibrosis by Modulating Lung Microbiota‐Derived Metabolism and Ameliorating Alveolar Epithelial Cell Senescence},
journal = {Phytotherapy Research},
year = {2025},
doi = {10.1002/ptr.8374}
}
EUVIMED